RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION
Abstract
The paper analyzes the results of treatment in 5,396 patients with multidrug-resistant tuberculosis who were treated in the regions of the Russian Federation under the Global Fund Round 4 project based on the recommended World Health Organization principles in the software management of drug-resistant tuberculosis. In the patients with multidrug-resistant tuberculosis, the total efficiency of chemotherapy was 49.6% and the efficiency of treatment in new multidrug-resistant tuberculosis cases was 59.5%. The main poor outcome of chemotherapy was its discontinuation that was 21.8%. The efficiency of chemotherapy in patients with multidrug resistant tuberculosis in the regions of the Russian Federation corresponds to that of treatment in the countries of the world and Europe.
About the Authors
V. V. Testov
ФГБУ «Центральный НИИ туберкулеза» РАМН
Russian Federation
Russian Federation
S. A. Sterlikov
Центральный научно-исследовательский институт организации и информатизации здравоохранения
Russian Federation
Russian Federation
I. A. Vasilyeva
ФГБУ «Центральный НИИ туберкулеза» РАМН
Russian Federation
Russian Federation
V. V. Erokhin
ФГБУ «Центральный НИИ туберкулеза» РАМН
Russian Federation
Russian Federation
T. Ch. Kesaeva
Министерство здравоохранения Российской Федерации
Russian Federation
г. Москва
Russian Federation
г. Москва
References
1. Литература Васильева И. А., Эргешов А. Э., Самойлова А. Г. и др. Отдаленные результаты применения стандартных режимов химиотерапии у больных туберкулезом органов дыхания // Туб. - 2012. - № 4. - С. 3-8.
2. Инструкции по оформлению заявки в Комитет зеленого света по обеспечению противотуберкулезными препаратами второго ряда//WHO/HTM/TB/2006.369.
3. Туберкулез в Российской Федерации 2011 г. Аналитический обзор статистических показателей, используемых в Российской Федерации и в мире. - М., 2013. - 280 с.
4. Global TB Report 2011// WHO/HTM/TB/2011.16.
5. Global TB Report 2013// WHO/HTM/TB/2013.11.
6. Guidelines for the programmatic management of drug-resistant tuberculosis// WHO/HTM/TB/2006.361
7. Keshavjee S., Gelmanova I. Y., Farmer P. E. et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study // Lancet. - 2008. - Vol. 372, № 9647. - Р. 1403-1409.
Review
For citations:
Testov V.V., Sterlikov S.A., Vasilyeva I.A., Erokhin V.V., Kesaeva T.Ch. RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION. Tuberculosis and Lung Diseases. 2014;(4):9-13. (In Russ.)
Views:
874
Email this article 